Piramal Pharma Shareholding Pattern
- Market cap
- ₹26,843 crore
- P/E
- 22.5
- P/B
- 3.29
- ROE
- -4.0%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 34.80% of Piramal Pharma (-0.06 pp from 31-MAR-2026), foreign institutional investors 12.52%, domestic institutions 14.57% and the public 37.63%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Piramal Pharma shareholding pattern — frequently asked questions
What is the promoter holding in Piramal Pharma?
Promoters held 34.80% of Piramal Pharma as of 30-JUN-2026, down 0.06 pp from 34.86% in 31-MAR-2026.
How much do FIIs hold in Piramal Pharma?
Foreign institutional investors held 12.52% of Piramal Pharma as of 30-JUN-2026, a change of -17.66 pp from the previous quarter.
How much do domestic institutions hold in Piramal Pharma?
Domestic institutional investors, including mutual funds and insurers, held 14.57% of Piramal Pharma as of 30-JUN-2026 (-1.04 pp from the previous quarter).
Who owns Piramal Pharma?
As of 30-JUN-2026, Piramal Pharma's shareholders were promoters (34.80%), foreign institutional investors 12.52%, domestic institutions 14.57% and the public 37.63%, as filed with the stock exchanges.
Same Data For Peers
Trade Piramal Pharma With ATS
Track PPLPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.